With ten studies, RASSF1A was the most frequently evaluated gene and eight of them reported higher frequency of methylated RASSF1A in BC patients compared to controls [42, 44–46, 50, 52, 55–58]. The gene discussed is RASSF1; the disease is breast cancer.